| FGFR1 |
FGFR1, FGFBR, FLG, FLT2: Basic fibroblast growth factor receptor 1 precursor |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
0.468 |
Evidence |
|
| PF4V1 |
PF4V1, SCYB4V1: Platelet factor 4 variant precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| PF4V1 |
PF4V1, SCYB4V1: Platelet factor 4 variant precursor |
DPP8 |
DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 |
0.468 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| IL8 |
IL8: Interleukin-8 precursor |
DPP8 |
DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 |
0.468 |
Evidence |
|
| GNAO1 |
GNAO1: Guanine nucleotide-binding protein G(o) subunit alpha 1 |
BDKRB2 |
BDKRB2, BKR2: B2 bradykinin receptor |
0.468 |
Evidence |
|
| CXCL1 |
CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| CXCL1 |
CXCL1, GRO, GRO1, GROA, MGSA, SCYB1: Growth-regulated protein alpha precursor |
DPP8 |
DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 |
0.468 |
Evidence |
|
| GNAI3 |
GNAI3: Guanine nucleotide-binding protein G(k) subunit alpha |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
AP2B1 |
AP2B1: Uncharacterized protein AP2B1 |
0.468 |
Evidence |
|
| RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
STAT4 |
STAT4: Signal transducer and activator of transcription 4 |
0.468 |
Evidence |
|
| RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
0.468 |
Evidence |
|
| RET |
RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor |
STAT2 |
STAT2: Signal transducer and activator of transcription 2 |
0.468 |
Evidence |
|
| HRG |
HRG: Histidine-rich glycoprotein precursor |
CAPN3 |
CAPN3, CANP3, CANPL3, NCL1: Calpain-3 |
0.468 |
Evidence |
|
| BGLAP |
BGLAP: Osteocalcin precursor |
CDO1 |
CDO1: Cysteine dioxygenase type 1 |
0.468 |
Evidence |
|
| CXCL10 |
CXCL10, INP10, SCYB10: Small-inducible cytokine B10 precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| CXCL10 |
CXCL10, INP10, SCYB10: Small-inducible cytokine B10 precursor |
DPP8 |
DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 |
0.468 |
Evidence |
|
| PF4 |
PF4, CXCL4, SCYB4: Platelet factor 4 precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| PF4 |
PF4, CXCL4, SCYB4: Platelet factor 4 precursor |
DPP8 |
DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 |
0.468 |
Evidence |
|
| PPBP |
PPBP, CTAP3, SCYB7, TGB1, THBGB1: Platelet basic protein precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.468 |
Evidence |
|
| PPBP |
PPBP, CTAP3, SCYB7, TGB1, THBGB1: Platelet basic protein precursor |
DPP8 |
DPP8, DPRP1, MSTP097, MSTP135, MSTP141: Dipeptidyl peptidase 8 |
0.468 |
Evidence |
|
| AHSG |
AHSG, FETUA, PRO2743: Alpha-2-HS-glycoprotein precursor |
CAPN3 |
CAPN3, CANP3, CANPL3, NCL1: Calpain-3 |
0.468 |
Evidence |
|
| CST4 |
CST4: Cystatin-S precursor |
CTSZ |
CTSZ: Cathepsin Z precursor |
0.468 |
Evidence |
|
| CST4 |
CST4: Cystatin-S precursor |
CTSC |
CTSC, CPPI: Dipeptidyl-peptidase 1 precursor |
0.468 |
Evidence |
|
| CST4 |
CST4: Cystatin-S precursor |
CTSS |
CTSS: Cathepsin S precursor |
0.468 |
Evidence |
|